申请人:MERCK & CO INC
公开号:WO2001070229A1
公开(公告)日:2001-09-27
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions and are selected from the group (I) or a pharmaceutically acceptable salt thereof, wherein T is selected from the group (II) and (III), and ;D, E, F, G, H, I, and J are independently N or C Y1, provided that the number of such variables D, E, F, G, H, I, and J representing N is 0, 1, or 2; K, L, M and Q are independently NH or C Y1Y2, provided that the number of such variables D, E, F, K, L, M, and Q representing N is 0, 1, or 2;Y?1 and Y2¿ are independently selected from the group consisting of hydrogen, C¿1-4? alkyl, halogen, amino, or hydroxy; A is (IV), (V), (VI), or (VII).